West Pharmaceutical Services, Inc. Share Price
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
14:45:38 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 411.80 USD | -1.17% |
|
+4.80% | +49.36% |
| 02:36pm | Stephens Adjusts West Pharmaceutical Services Price Target to $490 From $450 | MT |
| 01:01pm | Deutsche Bank Adjusts West Pharmaceutical Services PT to $450 From $420, Maintains Buy Rating | MT |
| Market Cap | 29.32B 26.27B 24.23B 21.93B 41B 2,792B 41.67B 289B 115B 1,461B 110B 108B 4,629B | P/E 2026 * |
48.6x | P/E 2027 * | 42.2x |
|---|---|---|---|---|---|
| Enterprise Value | 28.82B 25.81B 23.82B 21.55B 40.3B 2,744B 40.95B 284B 113B 1,436B 108B 106B 4,549B | EV / Sales 2026 * |
8.54x | EV / Sales 2027 * | 7.92x |
| Free-Float |
91.77% | Yield 2026 * |
0.22% | Yield 2027 * | 0.22% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WST | Delayed | |
CBOE
| WST | Real-time | |
|
London S.E.
| 0ADY | Delayed | |
|
Boerse Muenchen
| WPS | Real-time | |
|
Tradegate
| WPS | Real-time | |
|
Deutsche Boerse AG
| WPS | Delayed | |
|
Börse Stuttgart
| WPS | Delayed | |
|
Berne S.E.
| WPS | End-of-day quote | |
|
Borsa Italiana
| 1WST | End-of-day quote |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | -1.53% | ||
| 1 week | +4.80% | ||
| Current month | +10.84% | ||
| 1 month | +10.84% | ||
| 3 months | +21.02% | ||
| 6 months | +38.10% | ||
| Current year | +49.36% |
| 1 week | 388.06 |  | 438.27 |
| 1 month | 359.49 | | 438.27 |
| Current year | 223.83 | | 438.27 |
| 1 year | 223.83 | | 438.27 |
| 3 years | 187.43 | | 438.27 |
| 5 years | 187.43 | | 475 |
| 10 years | 72.76 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 30/08/2026 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 03/08/2025 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 31/01/2011 |
Douglas Michels
BRD | Director/Board Member | 69 | 06/03/2011 |
William Feehery
BRD | Director/Board Member | 56 | 11/02/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Other | Director | 44 | 0.0001% | ||
| 15/09/26 | Exercice | Head of Human Resources | 7,572 | 0.0108% | ||
| 08/09/26 | Free | Chief Executive Officer | 51,798 | 0.0736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.17% | +4.80% | +47.54% | +28.48% | 29.32B | |
| +1.00% | +2.54% | -14.71% | +14.33% | 181B | |
| -5.48% | -4.08% | -20.15% | +12.20% | 120B | |
| -0.14% | +1.81% | +6.78% | +38.83% | 119B | |
| +3.76% | +1.74% | -42.30% | +9.55% | 91.44B | |
| +0.67% | +0.89% | -2.13% | +80.11% | 63.07B | |
| -0.46% | +0.42% | +8.19% | +82.97% | 55.8B | |
| +0.02% | -0.07% | +10.81% | -20.84% | 54.03B | |
| -2.01% | +1.53% | -9.48% | +43.53% | 45.38B | |
| +0.54% | +2.31% | -0.77% | -6.14% | 34.37B | |
| Average | -0.46% | +1.01% | -1.62% | +28.30% | 79.28B | |
| Weighted average by Cap. | -0.41% | +0.94% | -7.93% | +26.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.37B 3.02B 2.79B 2.52B 4.72B 321B 4.8B 33.27B 13.27B 168B 12.67B 12.4B 533B | 3.59B 3.21B 2.96B 2.68B 5.02B 342B 5.1B 35.37B 14.11B 179B 13.46B 13.18B 566B |
| Net income | 619M 554M 511M 463M 865M 58.92B 879M 6.1B 2.43B 30.84B 2.32B 2.27B 97.67B | 710M 636M 586M 531M 992M 67.58B 1.01B 7B 2.79B 35.37B 2.66B 2.61B 112B |
| Net Debt | -503M -451M -416M -376M -704M -47.93B -715M -4.96B -1.98B -25.08B -1.89B -1.85B -79.44B | -923M -827M -763M -690M -1.29B -87.93B -1.31B -9.1B -3.63B -46.02B -3.47B -3.39B -146B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$410.92 | -1.38% | 190,576 |
| 29/10/26 | US$416.67 | +3.23% | 1,873,145 |
| 28/10/26 | US$403.64 | +1.34% | 773,291 |
| 27/10/26 | US$398.29 | +0.90% | 790,686 |
| 26/10/26 | US$394.73 | +0.66% | 649,659 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
